In vitro characterization and in vivo application of a dual functional peptide

Proceedings - 2013 7th International Conference on Complex, Intelligent, and Software Intensive Systems, CISIS 2013

Volumn , Issue , 2013, Pages 576-581

  Chen, Chien Jung ^a   Kuo, Ping Hsueh ^a   Hung, Ta Jen ^a   Fang, Shun Lung ^a   Yang, Che Chuan ^b   Yang, Shieh Yueh ^b   Chang, Margaret Dah Tsyr ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b MAGQU CO LTD   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING AFFINITIES; CANCER-TARGETING; CATIONIC PROTEINS; FUNCTIONAL PEPTIDES; HEPARIN-BINDING REGIONS; MAGNETIC NANO-PARTICLES; QUANTITATIVE ASSAY; SULFATED GLYCOSAMINOGLYCANS;

BINDING ENERGY; CELL CULTURE; DIAGNOSIS; DISEASES; MAGNETIC RESONANCE IMAGING; MAMMALS; MOLECULAR IMAGING; PEPTIDES; SYNTHESIS (CHEMICAL); TUMORS;

CELL MEMBRANES;

EID: 84885232154     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/CISIS.2013.104     Document Type: Conference Paper

References (47)

1. Gandhi, N.S. and R.L. Mancera, The structure of glycosaminoglycans and their interactions with proteins. Chem Biol Drug Des, 2008. 72(6): p. 455-82.
2. Raman, K. and B. Kuberan, Chemical Tumor Biology of Heparan Sulfate Proteoglycans. Curr Chem Biol, 2010. 4(1): p. 20-31.
3. Matsuda, K., et al., Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells. Cancer Res, 2001. 61(14): p. 5562-9.
4. Vlodavsky, I. and Y. Friedmann, Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest, 2001. 108(3): p. 341-7.
5. Yang, N., et al., Syndecan-1 in breast cancer stroma fibroblasts regulates extracellular matrix fiber organization and carcinoma cell motility. Am J Pathol, 2011. 178(1): p. 325-35.
6. Tavassoli, F.A., Breast pathology: rationale for adopting the ductal intraepithelial neoplasia (DIN) classification. Nat Clin Pract Oncol, 2005. 2(3): p. 116-7.
7. Abes, R., et al., Cell-penetrating-peptide-based delivery of oligonucleotides: an overview. Biochem Soc Trans, 2007. 35(Pt 4): p. 775-9.
8. Choi, Y.S., et al., The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine. Biomaterials, 2010. 31(6): p. 1429-43.
9. Vives, E., J. Schmidt, and A. Pelegrin, Cell-penetrating and celltargeting peptides in drug delivery. Biochim Biophys Acta, 2008. 1786(2): p. 126-38.
10. Ziegler, A., Thermodynamic studies and binding mechanisms of cellpenetrating peptides with lipids and glycosaminoglycans. Adv Drug Deliv Rev, 2008. 60(4-5): p. 580-97.
11. Sawant, R. and V. Torchilin, Intracellular transduction using cellpenetrating peptides. Mol Biosyst, 2010. 6(4): p. 628-40.
12. Heitz, F., M.C. Morris, and G. Divita, Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br J Pharmacol, 2009. 157(2): p. 195-206.
13. Vives, E., P. Brodin, and B. Lebleu, A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem, 1997. 272(25): p. 16010-7.
14. Wadia, J.S., R.V. Stan, and S.F. Dowdy, Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med, 2004. 10(3): p. 310-5.
15. Elliott, G. and P. O'Hare, Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell, 1997. 88(2): p. 223-33.
16. Sugita, T., et al., Comparative study on transduction and toxicity of protein transduction domains. Br J Pharmacol, 2008. 153(6): p. 1143-52.
17. Mager, I., et al., Assessing the uptake kinetics and internalization mechanisms of cell-penetrating peptides using a quenched fluorescence assay. Biochim Biophys Acta, 2010. 1798(3): p. 338-43.
18. El-Andaloussi, S., et al., Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study. Biochem J, 2007. 407(2): p. 285-92.
19. Soomets, U., et al., Deletion analogues of transportan. Biochim Biophys Acta, 2000. 1467(1): p. 165-76.
20. McLaren, D.J., et al., Morphological studies on the killing of schistosomula of Schistosoma mansoni by human eosinophil and neutrophil cationic proteins in vitro. Parasite Immunol, 1981. 3(4): p. 359-73.
21. Ackerman, S.J., et al., Comparative toxicity of purified human eosinophil granule cationic proteins for schistosomula of Schistosoma mansoni. Am J Trop Med Hyg, 1985. 34(4): p. 735-45.
22. Maeda, T., et al., Growth inhibition of mammalian cells by eosinophil cationic protein. Eur J Biochem, 2002. 269(1): p. 307-16.
23. Motojima, S., et al., Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Am Rev Respir Dis, 1989. 139(3): p. 801-5.
24. Carreras, E., et al., Surface-exposed amino acids of eosinophil cationic protein play a critical role in the inhibition of mammalian cell proliferation. Mol Cell Biochem, 2005. 272(1-2): p. 1-7.
25. Boix, E., et al., Kinetic and product distribution analysis of human eosinophil cationic protein indicates a subsite arrangement that favors exonuclease-type activity. J Biol Chem, 1999. 274(22): p. 15605-14.
26. Cardin, A.D. and H.J. Weintraub, Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis, 1989. 9(1): p. 21-32.
27. Lien, P.-C., et al., In Silico Prediction and In Vitro Characterization of Multifunctional Human RNase3. BioMed Research International, 2013. 2013: p. 12.
28. Fang, S.L., et al., A novel cell-penetrating Peptide derived from human eosinophil cationic protein. PLoS One, 2013. 8(3): p. e57318.
29. Yang, S.Y., et al., A novel quantitative immunomagnetic reduction assay for Nervous necrosis virus. J Vet Diagn Invest, 2012. 24(5): p. 911-7.
30. Chieh, J.J., et al., Hyper-high-sensitivity wash-free magnetoreduction assay on biomolecules using high-T(c) superconducting quantum interference devices. Journal of Applied Physics, 2008. 103(1).
31. Hahn, M.A., et al., Nanoparticles as contrast agents for in-vivo bioimaging: current status and future perspectives. Anal Bioanal Chem, 2011. 399(1): p. 3-27.
32. Johnson, R.J., et al., Inhibition of human pancreatic ribonuclease by the human ribonuclease inhibitor protein. J Mol Biol, 2007. 368(2): p. 434-49.
33. Gleich, G.J., et al., Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. Proc Natl Acad Sci U S A, 1986. 83(10): p. 3146-50.
34. Gabay, J.E., et al., Antibiotic proteins of human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A, 1989. 86(14): p. 5610-4.
35. Yang, D., et al., Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation. J Immunol, 2004. 173(10): p. 6134-42.
36. Seno, M., et al., Molecular cloning and expression of human ribonuclease 4 cDNA. Biochim Biophys Acta, 1995. 1261(3): p. 424-6.
37. Di Liddo, R., et al., In vitro biological activity of bovine milk ribonuclease-4. Mol Med Report, 2010. 3(1): p. 127-32.
38. Saxena, S.K., et al., Angiogenin is a cytotoxic, tRNA-specific ribonuclease in the RNase A superfamily. J Biol Chem, 1992. 267(30): p. 21982-6.
39. Tsirakis, G., et al., Role of platelet-derived growth factor-AB in tumour growth and angiogenesis in relation with other angiogenic cytokines in multiple myeloma. Hematol Oncol, 2011.
40. Wiedlocha, A., Following angiogenin during angiogenesis: a journey from the cell surface to the nucleolus. Arch Immunol Ther Exp (Warsz), 1999. 47(5): p. 299-305.
41. Rosenberg, H.F. and K.D. Dyer, Molecular cloning and characterization of a novel human ribonuclease (RNase k6): increasing diversity in the enlarging ribonuclease gene family. Nucleic Acids Res, 1996. 24(18): p. 3507-13.
42. Torrent, M., et al., Comparison of the membrane interaction mechanism of two antimicrobial RNases: RNase 3/ECP and RNase 7. Biochim Biophys Acta, 2009. 1788(5): p. 1116-25.
43. Huang, Y.C., et al., The flexible and clustered lysine residues of human ribonuclease 7 are critical for membrane permeability and antimicrobial activity. J Biol Chem, 2007. 282(7): p. 4626-33.
44. Zhang, J., K.D. Dyer, and H.F. Rosenberg, RNase 8, a novel RNase A superfamily ribonuclease expressed uniquely in placenta. Nucleic Acids Res, 2002. 30(5): p. 1169-75.
45. Liu, J., et al., Cloning, expression and location of RNase9 in human epididymis. BMC Res Notes, 2008. 1: p. 111.
46. Cheng, G.Z., et al., Human ribonuclease 9, a member of ribonuclease A superfamily, specifically expressed in epididymis, is a novel spermbinding protein. Asian J Androl, 2009. 11(2): p. 240-51.
47. Kondo, E., et al., Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems. Nat Commun, 2012. 3: p. 951.